Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health

Clinical Innovation

foldavalve
CTSA Program Supports Development and De-Risking of Heart Valve Technology

NCATS’ Clinical and Translational Science Awards (CTSA) Program support enabled the early development of an innovative device that may help patients avoid complications of heart valve replacement.

Dr. Rupa Patel
CTSA Program Researcher Studies Barriers to HIV Prevention

With NCATS-supported mentoring and training, an early-stage investigator is studying barriers that keep young adults from obtaining HIV prevention medicines.

Clinical & Translational Science Awards (CTSA) Program

The CTSA Program is designed to strengthen and support the entire spectrum of translational research from scientific discovery to improved patient care.

Rare Diseases Clinical Research Network (RDCRN)

The RDCRN is designed to advance medical research on rare diseases by facilitating collaboration, study enrollment and data sharing.

Patient Registries

Patient and contact registries are key tools that help researchers identify potential clinical study participants, including healthy volunteers.

Clinical Research Toolbox

NCATS supports clinical research tools that facilitate trial design, patient recruitment and partnerships for commercialization.

Clinical & Translational Science Awards (CTSA) Program

The CTSA Program is designed to strengthen and support the entire spectrum of translational research from scientific discovery to improved patient care.

Rare Diseases Clinical Research Network (RDCRN)

The RDCRN is designed to advance medical research on rare diseases by facilitating collaboration, study enrollment and data sharing.

Patient Registries

Patient and contact registries are key tools that help researchers identify potential clinical study participants, including healthy volunteers.

Clinical Research Toolbox

NCATS supports clinical research tools that facilitate trial design, patient recruitment and partnerships for commercialization.

Work with Us

NCATS aims to address common barriers in clinical and translational research that scientists nationwide face every day, with the goal of delivering more treatments to more patients more quickly.

Contact the Division of Clinical Innovation

Learn more about NCATS’ Achievements in Advancing Translational Sciences.

Clinical Trials

NCATS programs support a broad range of clinical research, including clinical trials. NCATS authorization (PDF - 133KB) limits specific support for clinical trials only through the end of Phase IIA.

Phase II clinical trials are designed to test drugs for efficacy (or effectiveness) and side effects in a limited number of patients. Phase IIA trials provide data for exposure-response in patients, while Phase IIB trials provide data for dose-ranging in patients.

Addressing Clinical Research Challenges

Researchers nationwide face common barriers in clinical and translational research that can delay the development of new interventions for patients in need. These challenges include:

  • Difficulties in recruiting, mentoring and retaining a critical mass of qualified clinical and translational investigators
  • Increased research costs and complexity
  • Low patient recruitment and retention in clinical research studies
  • Inflexible study designs
  • Increased regulatory burdens

NCATS supports innovative programs, such as the Clinical and Translational Science Awards (CTSA) Program and Rare Diseases Clinical Research Network (RDCRN), to help address these challenges.